33 related articles for article (PubMed ID: 9252683)
1. Assessment of the innervation pattern of oral squamous cell carcinoma using neural protein gene product (9.5)-An immunocytochemical study.
Habash FS; Hantash RO; Yunis MA
J Oral Maxillofac Pathol; 2012 Jan; 16(1):16-21. PubMed ID: 22434940
[TBL] [Abstract][Full Text] [Related]
2. The Potentiality of Prostate-Specific Antigen as a Prognostic Biomarker in Breast Cancer.
Bouaod W; Zakoko AM; Asif H; Hussain A; Malik N; Ray SD; Peela J; Teja Peela AS; Jarari AM
Cureus; 2023 Sep; 15(9):e44621. PubMed ID: 37799254
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712
[TBL] [Abstract][Full Text] [Related]
4. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
5. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
6. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen may serve as a pathological predictor in breast cancer.
NariĊ£a D; Anghel A; Motoc M
Rom J Morphol Embryol; 2008; 49(2):173-80. PubMed ID: 18516323
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
[TBL] [Abstract][Full Text] [Related]
9. [Prostate-specific antigen (PSA) in women].
Kamenov Z; Todorova M; Khristov V
Vutr Boles; 2001; 33(1):40-7. PubMed ID: 11785088
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) in women.
Yu H; Berkel H
J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
12. Human prostate cancer progression models and therapeutic intervention.
Chung LW; Kao C; Sikes RA; Zhau HE
Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]